This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Q&A with Dr Kevin Fernando: When to individualise HbA1c targets

Length: 01:15

A short Q&A with Dr Kevin Fernando about when to individualise HbA1c targets.

“An HbA1c level of <7% (53 mmol/mol) is usually considered to be an initial glycaemic target for patients with T2DM. For which patient groups would you need to relax or adjust this target?”

More information about diabetes:

Supporting documentation

JANUVIA® (sitagliptin) 100 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

JANUVIA® (sitagliptin) 50 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

JANUVIA® (sitagliptin) 25 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-DIA-00185 | Date of Preparation: April 2019